Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.67 USD -3.47% Market Closed
Market Cap: 15.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Wall Street
Price Targets

TRIB Price Targets Summary
Trinity Biotech PLC

There are no price targets for TRIB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Trinity Biotech PLC Competitors:
Price Targets
DEMANT
Demant A/S
20% Upside
7716
Nakanishi Inc
17% Upside
OWLT
Owlet Inc
195% Upside
OPTOMED
Optomed Oyj
70% Upside
PRM
Prim SA
75% Upside
SOON
Sonova Holding AG
11% Downside
CYC
Cyclopharm Ltd
90% Upside
HYPR
Hyperfine Inc
30% Upside

Revenue
Forecast

Revenue Estimate
Trinity Biotech PLC

For the last 8 years the compound annual growth rate for Trinity Biotech PLC's revenue is -7%. The projected CAGR for the next 2 years is 14%.

-7%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Trinity Biotech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Trinity Biotech PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRIB's stock price target?
Not Available

TRIB doesn't have any price targets made by Wall Street professionals.

What is Trinity Biotech PLC's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Trinity Biotech PLC's revenue is -7%. The projected CAGR for the next 2 years is 14%.

Back to Top